These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12643420)

  • 1. Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.
    Potapov EV; Pasic M; Bauer M; Hetzer R
    Ann Thorac Surg; 2002 Dec; 74(6):2182-3. PubMed ID: 12643420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of recombinant factor VII to control bleeding in a patient supported by right ventricular assist device after heart transplantation.
    Kogan A; Berman M; Kassif Y; Raanani E; Stamler A; Ben Gal T; Stein M; Erez E; Vidne BA; Sahar G
    J Heart Lung Transplant; 2005 Mar; 24(3):347-9. PubMed ID: 15737765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
    Tarzia V; Buratto E; Bortolussi G; Paolini C; Bejko J; Bottio T; Gerosa G
    Artif Organs; 2015 Mar; 39(3):248-53. PubMed ID: 25065398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful use of recombinant factor VIIa in the control of a massive bleeding in two patients with biventricular assist device (Thoratec)].
    Fritsch N; Pouquet O; Roux B; Abdelmoumen Y; Janvier G
    Ann Fr Anesth Reanim; 2010 Jan; 29(1):45-7. PubMed ID: 20080378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor vii to control massive post operative bleeding after septic aortobifemoral grafting.
    Raux M; Chiche L; Vanhille E; Riou B
    Eur J Anaesthesiol; 2005 Oct; 22(10):805-7. PubMed ID: 16211789
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
    Kogan A; Berman M; Stein M; Vidne BA; Raanani E
    J Cardiovasc Surg (Torino); 2004 Dec; 45(6):569-71. PubMed ID: 15746637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory bleeding after endoscopic sphincterotomy: a new indication for recombinant factor VII therapy?
    Romero-Castro R; Jiménez-Sáenz M; Pellicer-Bautista F; Herrerías-Gutiérrez JM
    Am J Gastroenterol; 2004 Oct; 99(10):2063-5. PubMed ID: 15447774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven years' experience with the Pierce-Donachy ventricular assist device.
    Pennington DG; Kanter KR; McBride LR; Kaiser GC; Barner HB; Miller LW; Naunheim KS; Fiore AC; Willman V
    J Thorac Cardiovasc Surg; 1988 Dec; 96(6):901-11. PubMed ID: 3057290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of refractory bleeding after bridging from acute to chronic left ventricular assist device support with recombinant activated factor VII.
    Flynn JD; Camp PC; Jahania MS; Ramaiah C; Akers WS
    ASAIO J; 2004; 50(5):519-21. PubMed ID: 15497395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant activated factor VII for non-hemophiliac bleeding patients.
    Uhlmann EJ; Eby CS
    Curr Opin Hematol; 2004 May; 11(3):198-204. PubMed ID: 15257021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Activated recombinant factor VII for bleeding after a kidney transplant].
    Vidal MA; Sebastianes C; Eizaga R; Martínez E; Torres LM
    Rev Esp Anestesiol Reanim; 2005 Dec; 52(10):638-9. PubMed ID: 16435622
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
    Tofil NM; Winkler MK; Watts RG; Noonan J
    Pediatr Crit Care Med; 2005 May; 6(3):352-4. PubMed ID: 15857538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
    Cağlar K; Cetinkaya A; Aytaç S; Gümrük F; Gürgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):435-8. PubMed ID: 14631616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant activated factor VII after axillofemoral bypass grafting.
    Cheng CA; Ho AM
    Anaesth Intensive Care; 2006 Jun; 34(3):375-8. PubMed ID: 16802495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular assist device as a bridge to transplant, and extracorporeal membrane oxygenation for primary graft failure in a child with hemophilia A.
    Frías MÁ; Jaraba S; Ibarra I; Arroyo MJ; Velasco MJ; Ulloa E; Velasco F; Pérez-Navero JL
    Pediatr Crit Care Med; 2011 Nov; 12(6):e432-5. PubMed ID: 21926657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.
    Girisch M; Rauch R; Carbon R; Habash T; Hofbeck M
    Eur J Pediatr; 2004 Feb; 163(2):118-9. PubMed ID: 14716558
    [No Abstract]   [Full Text] [Related]  

  • 19. Five days of no anticoagulation or antiplatelet therapy and NovoSeven administration in a HeartWare HVAD patient.
    Saeed D; Albert A; Kamiya H; Maxhera B; Westenfeld R; Lichtenberg A
    Artif Organs; 2012 Aug; 36(8):751-3. PubMed ID: 22607278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery.
    Leibovitch L; Kenet G; Mazor K; Matok I; Vardi A; Barzilay Z; Paret G
    Pediatr Crit Care Med; 2003 Oct; 4(4):444-6. PubMed ID: 14525639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.